Literature DB >> 31209588

Effects of low level laser therapy in cancer cells-a systematic review of the literature.

Jéssica Lúcio da Silva1, Ana Flávia Spadaccini Silva-de-Oliveira1, Rodrigo Antonio Carvalho Andraus1, Luciana Prado Maia2,3.   

Abstract

The aim of the present study was to conduct a systematic review regarding the use of photobiomodulation (PBM) therapy in tumoral cells, addressing the different types of lasers and parameters used. An electronic search was performed in PubMed/MEDLINE, Cochrane Library, and EMBASE databases. The inclusion criteria were being an in vitro study, with tumoral cells, and have at least one group of treatment with low-power laser and a control group (without treatment). Were excluded studies that used only non-carcinogenic cells, in vivo studies, studies that used high-power laser or the association with photosensitizers. The primary outcome evaluated was the cellular viability, and the secondary outcomes were the apoptosis rate and gene and inflammatory mediators' expression. Nineteen studies were identified among the lists of citations of studies that met the exclusion/inclusion criteria. There is a wide divergence regarding the wavelengths and doses used, as well as the type of laser, and each variation leads to different results, with some studies showing an increase in cell proliferation, while other studies showed a decrease. It is possible to suggest that PBM can be used in cancerous lesions in order to decrease the proliferation of these cells depending on the parameters used; however, the lack of standardization of laser irradiation protocols for in vitro investigations does not allow the establishment of ideal parameters for this purpose. Therefore, PBM should be used with caution in cancer patients until more studies are performed.

Entities:  

Keywords:  Cancer cell; Laser therapy; Low level laser therapy; Neoplasms; Photobiomodulation therapy; Tumoral cell

Mesh:

Year:  2019        PMID: 31209588     DOI: 10.1007/s10103-019-02824-2

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  17 in total

1.  Low-Intensity Laser Irradiation at 636 nm Induces Increased Viability and Proliferation in Isolated Lung Cancer Stem Cells.

Authors:  Anine Crous; Heidi Abrahamse
Journal:  Photomed Laser Surg       Date:  2015-12-21       Impact factor: 2.796

2.  Effects of pre-radiation exposure to LLLT of normal and malignant cells.

Authors:  Andrei Barasch; Judith Raber-Durlacher; Joel B Epstein; James Carroll
Journal:  Support Care Cancer       Date:  2015-12-16       Impact factor: 3.603

3.  Exploring the effects of low-level laser therapy on fibroblasts and tumor cells following gamma radiation exposure.

Authors:  Camila Ramos Silva; Fernanda Viana Cabral; Claudinei Francisco Morais de Camargo; Silvia Cristina Núñez; Tania Mateus Yoshimura; Arthur Cássio de Lima Luna; Durvanei Augusto Maria; Martha Simões Ribeiro
Journal:  J Biophotonics       Date:  2016-06-20       Impact factor: 3.207

4.  Selective cytotoxic effects of low-power laser irradiation on human oral cancer cells.

Authors:  Wei-Zhe Liang; Pei-Feng Liu; Earl Fu; Hao-Sheng Chung; Chung-Ren Jan; Chih-Hsuan Wu; Chih-Wen Shu; Yao-Dung Hsieh
Journal:  Lasers Surg Med       Date:  2015-09-23       Impact factor: 4.025

5.  Low level laser therapy induces increased viability and proliferation in isolated cancer cells.

Authors:  C Kara; H Selamet; C Gökmenoğlu; N Kara
Journal:  Cell Prolif       Date:  2017-11-20       Impact factor: 6.831

6.  Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid.

Authors:  Fernanda Gonçalves Basso; Ana Paula Silveira Turrioni; Diana Gabiela Soares; Vanderlei Salvador Bagnato; Josimeri Hebling; Carlos Alberto de Souza Costa
Journal:  Support Care Cancer       Date:  2014-05-07       Impact factor: 3.603

7.  Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway.

Authors:  Felipe F Sperandio; Fernanda S Giudice; Luciana Corrêa; Décio S Pinto; Michael R Hamblin; Suzana C O M de Sousa
Journal:  J Biophotonics       Date:  2013-04-02       Impact factor: 3.207

8.  The effect of low-level laser irradiation (In-Ga-Al-AsP - 660 nm) on melanoma in vitro and in vivo.

Authors:  Lúcio Frigo; Juliana S S Luppi; Giovani M Favero; Durnavei A Maria; Sócrates C Penna; Jan M Bjordal; Rene J Bensadoun; Rodrigo A B Lopes-Martins
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

Review 10.  Lasers and intense pulsed light (IPL) association with cancerous lesions.

Authors:  Caerwyn Ash; Godfrey Town; Rebecca Whittall; Louise Tooze; Jaymie Phillips
Journal:  Lasers Med Sci       Date:  2017-09-07       Impact factor: 3.161

View more
  4 in total

1.  Effect of Low-Level Laser Therapy and Sinensetin (Combination therapy) on Tumor Cells (Hela) and Normal Cells (CHO).

Authors:  Behnam Javaheri; Gholamreza Esmaeeli Djavid; Kazem Parivar; Azadeh Hekmat
Journal:  J Lasers Med Sci       Date:  2021-12-27

2.  Photobiomodulation Therapy Affects the Elastic Modulus, Cytoskeletal Rearrangement and Migration Capability of Human Osteosarcoma Cells.

Authors:  Amin Barati Shoorche; Alireza Mohammadkarim; Majid Jadidi; Marjan Bahraminasab
Journal:  Lasers Med Sci       Date:  2022-04-08       Impact factor: 2.555

3.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Authors:  Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 4.  Safety and efficacy of photobiomodulation therapy in oncology: A systematic review.

Authors:  René-Jean Bensadoun; Joel B Epstein; Raj G Nair; Andrei Barasch; Judith E Raber-Durlacher; Cesar Migliorati; Marie-Thérèse Genot-Klastersky; Nathaniel Treister; Praveen Arany; Joy Lodewijckx; Jolien Robijns
Journal:  Cancer Med       Date:  2020-10-26       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.